ARTICLE | Financial News
Oxford Nanopore receives £50M investment from Amgen
October 19, 2018 7:38 PM UTC
Oxford Nanopore Technologies Ltd. (Oxford, U.K.) received an equity investment of £50 million ($65.6 million) on Oct. 18 from Amgen Inc. (NASDAQ:AMGN).
Amgen's deCODE Genetics subsidiary uses Oxford Nanopore's nanopore-based DNA and RNA sequencing technology to discover and validate new targets...